Summary

The coagulatory system in patients with COVID-19 is characterised by a distinctive and dynamic interplay between procoagulant and fibrinolytic pathways. Infection of endothelial cells by SARS-CoV-2 precipitates widespread endothelial dysfunction, leading to platelet activation, thrombin generation and pulmonary microthrombosis. Laboratory findings commonly include elevated D-dimers and fibrinogen levels alongside minimal early changes in clotting times and platelet count. As the disease progresses, a hypofibrinolytic state may develop, driven by increased levels of plasminogen activator inhibitor-1, further tipping the balance towards thrombosis. This coagulopathy is associated with venous and arterial thromboembolism, acute respiratory distress syndrome and multi-organ impairment, contributing substantially to morbidity and mortality worldwide. Understanding these haemostatic disturbances has guided prophylactic anticoagulation strategies and underpins ongoing efforts to refine personalised therapeutic approaches.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Coagulation Dynamics in COVID-19 Patients publication trend

The graph below shows the total number of articles in coagulation dynamics in covid-19 patients across all publications each year (not limited to Nature Index journals).

Technical terms

Coagulopathy: A pathological state in which the blood’s ability to form clots is impaired or dysregulated, often leading to excessive bleeding or thrombosis.

Fibrinolysis: The enzymatic process that dissolves fibrin clots, primarily mediated by plasmin after its activation from plasminogen.

D-dimer: A fibrin degradation product present in the blood following clot breakdown; elevated levels indicate increased clot formation and lysis.

Endotheliopathy: Dysfunction or injury of the vascular endothelium, resulting in impaired barrier function, altered antithrombotic properties and promotion of inflammation.

References

  1. COVID–19-associated coagulopathy: An exploration of mechanisms. Vascular Medicine (2020).
  2. The unique characteristics of COVID-19 coagulopathy. Critical Care (2020).
  3. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19. Frontiers in Immunology (2024).
  4. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19. Journal of Thrombosis and Haemostasis (2020).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.